We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





PCR of Gargle Lavage Samples as Effective as Nasopharyngeal Swabs to Identify SARS-CoV-2 Infection, Finds Study

By LabMedica International staff writers
Posted on 30 Jul 2021
Twenty-six subjects from a cohort of 80 tested positive for SARS-CoV-2 via nasopharyngeal swab, and all 26 tested positive using gargle lavage (mouthwash), according to new research. More...


The detection method for testing samples used in this study by researchers from University of Konstanz (Konstanz, Germany) was the highly sensitive real time polymerase chain reaction (RT-PCR). Nasopharyngeal swabbing, currently the gold standard for collecting samples for COVID testing, has a low rate of acceptance due to the discomfort of having a nasal passage swabbed.

“Our results show that in all cases, where people were positively tested by the gold standard nasal swabbing, one could also detect the virus in gargle lavage by the same RT-PCR method,” said corresponding author Christof R. Hauck, PhD, professor of cell biology, Faculty of Natural Sciences, Department of Biology, University of Konstanz, Germany.
This sampling procedure can be conducted safely in a general practitioner’s office without extra protective equipment for physicians’ staff, as the patients themselves perform the sampling,” said Dr. Hauck. “We usually sent the patients with the gargle solution and sampling container outside.” There, they gargled in front of a window, observed by a physician’s staff member. Thus, “we need not expose trained personnel to the danger of taking samples from so many potentially infected people.”

Study subjects had typical respiratory symptoms or known contact with infected persons. Each received both a nasal swab administered by a professional health practitioner, “which was needed for the regular diagnostic procedure, and each self–performed a gargle lavage,” said Dr. Hauck. “These paired samples were then transferred to the central diagnostic lab, where they were analyzed in parallel, so that the results could be directly compared.”

“Besides performing diagnostics on symptomatic patients, we are involved in regular SARS-CoV-2 surveillance on our university campus, where we test people twice a week. As nasal swabbing is not very pleasant, we were looking for an alternative, and gargle lavage turned out to be highly accepted,” said Dr. Hauck.

“By finding complete congruence of results obtained with paired samples of a sizeable patient cohort, our results strongly support the idea that the painless self-collection of gargle lavage provides a suitable and uncomplicated source for reliable SARS-CoV-2 detection,” said Dr. Hauck.

Related Links:
University of Konstanz


Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
SARS-CoV-2 PCR Test
Macurra SARS-CoV-2 PCR Kit
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Single Genetic Analysis Identifies Causes of Premature Ovarian Insufficiency

Premature ovarian insufficiency (POI) affects up to 3.5% of women and represents a major cause of infertility. In most cases, the underlying etiology remains unknown, making patient counseling and clinical... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.